NeoGenomics, Inc. 0.25% 15-JAN-2028NeoGenomics, Inc. 0.25% 15-JAN-2028NeoGenomics, Inc. 0.25% 15-JAN-2028

NeoGenomics, Inc. 0.25% 15-JAN-2028

No trades
See on Supercharts

NEO5107997 analysis



Key facts


Issue date
Jan 11, 2021
Maturity date
Jan 15, 2028
Outstanding amount
‪345.00 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
0.25% (Fixed)
Yield to maturity
6.68%
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.